747 studies found for:    "Venous Thromboembolism"
Show Display Options
Rank Status Study
21 Recruiting Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy
Conditions: Venous Thromboembolism;   Haemorrhage
Interventions: Drug: Rivaroxaban;   Drug: placebo
22 Completed YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness
Condition: Venous Thromboembolism
Intervention: Drug: YM150
23 Enrolling by invitation Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients
Conditions: Venous Thromboembolism;   Pulmonary Embolus;   Deep Vein Thrombosis
Intervention:
24 Not yet recruiting Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Sodium enoxaparin;   Drug: Sodium Enoxaparin clexane
25 Withdrawn Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients
Condition: Venous Thromboembolism
Intervention: Other: Application of VTE Risk Assessment
26 Completed Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
Condition: Venous Thromboembolism
Intervention:
27 Recruiting Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans
Conditions: Cancer;   Venous Thromboembolism
Intervention: Behavioral: Questionnaires
28 Completed
Has Results
The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma
Condition: Venous Thromboembolism
Interventions: Drug: Dalteparin sodium;   Drug: Dalteparin sodium/aspirin
29 Completed A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: YM150;   Procedure: mechanical prophylaxis
30 Not yet recruiting Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Dabigatran;   Drug: Rivaroxaban;   Drug: Nadroparin
31 Completed A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Prevention;   Venous Thromboembolism
Interventions: Drug: edoxaban;   Drug: enoxaparin sodium
32 Completed Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Semuloparin Sodium;   Drug: Enoxaparin sodium;   Drug: Placebo
33 Completed A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Anticoagulants;   Venous Thromboembolism;   Thromboembolism;   Thrombosis;   Enoxaparin Sodium;   Embolism and Thrombosis;   Deep Vein Thrombosis;   DU-176b;   Edoxaban;   Factor Xa;   Oral;   Arthroplasty, Replacement, Hip
Interventions: Drug: DU-176V 15 mg tablets oral, once daily for 2 weeks;   Drug: DU-176b 30 mg tablets, oral once daily for 2 weeks;   Drug: Enoxaparin sodium 20 mg (=2000IU) / 0.2ml twice daily, subcutaneous
34 Active, not recruiting A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
Conditions: Deep Vein Thrombosis;   Coronary Artery Bypass Surgery;   Venous Thromboembolism
Interventions: Drug: Fondaparinux;   Other: Placebo
35 Completed A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Total Knee Arthroplasty;   DU-176b;   Factor Xa
Interventions: Drug: DU-176b;   Drug: Placebo
36 Completed Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery
Condition: Venous Thromboembolism
Interventions: Drug: DU-176b (edoxaban);   Drug: Enoxaparin sodium 20mg
37 Terminated
Has Results
Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients
Condition: Venous Thromboembolism
Interventions: Drug: Dalteparin (Fragmin);   Drug: Unfractionated heparin
38 Unknown  The Swiss Venous Thromboembolism Cohort 65+
Condition: Venous Thromboembolism
Intervention:
39 Completed Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Conditions: Venous Thromboembolism;   Deep-Vein Thrombosis;   Pulmonary Embolism;   Cancer
Intervention:
40 Recruiting Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism
Conditions: Venous Thromboembolism;   Deep-Vein Thrombosis;   Pulmonary Embolism;   Cancer
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years